YOLFTbeta
Jinling Pharmaceutical Co Ltd

Jinling Pharmaceutical Co Ltd

000919 · SHE · Healthcare / Drug Manufacturers - Specialty & Generic

6.07CNY-0.14 (-2.25%)

Price History

Full chart

Market Stats

Previous Close6.21
Open6.20
Day Range6.01 – 6.23
52-Week Range5.67 – 9.64
Volume23.96M
Market Cap4.04B
P/E (TTM)72.22
Forward P/E32.26
EPS0.09
Dividend Yield1.56%
Beta0.22
50-Day Avg6.53
200-Day Avg7.00

About

Jinling Pharmaceutical Company Limited, together with its subsidiaries, manufactures and sells pharmaceuticals and medical devices in China and internationally. It offers Mailuoning injection and oral solution for the treatment of thromboangiitis and arteriosclerosis obliterans, as well as cerebral and venous thrombosis; Sulifei, a ferrous succinate tablet for the prevention and treatment of iron deficiency anemia; Lentinan injection, an adjuvant therapy for the treatment of malignant tumors; and absorbable gelatin sponges for the treatment of wound bleeding and trauma hemostasis. The company also provides traditional Chinese medicines, chemical medicines, active pharmaceutical ingredients, and pharmaceutical intermediates. In addition, it engages in elderly care services, rehabilitation therapy, psychological counseling, and end-of-life care; hospital management; technical services; and healthcare investment activities. The company was incorporated in 1998 and is headquartered in Nanjing, China.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Hai Chen
  • Employees5.72K
  • HeadquartersJinling Pharmaceutical Building, Nanjing, China, 210009, China
  • Websitehttps://jlyy1999.com

Leadership

  • Mr. Hai ChenPresident & Director · b. 1980
  • Mr. Yang WangVP, Chief Accountant, Secretary, Financial Manager & Non-Independent Director · b. 1978
  • Mr. Quan LiChief Economist · b. 1978
  • Ms. Mingyi JiaChief Engineer · b. 1973
  • Mr. Jian WangExecutive Vice President · b. 1973
  • Mr. Jian LiVice President · b. 1985
  • Mr. Xinning ZhuAssistant to President · b. 1971
  • Mr. Zhenxin XiGeneral Manager Assistant · b. 1968
  • Ms. Xin LiuAssistant to the President · b. 1979
  • Mr. Yuan Xin FanAssistant to the President · b. 1971

Financials

Income Statement

Currency: CNY1996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue196.83M301.40M339.05M354.14M364.95M499.42M629.56M849.72M1.00B1.24B1.38B1.55B1.79B1.97B2.16B2.26B2.30B2.61B2.77B3.22B3.58B3.19B2.90B2.53B2.50B2.81B2.67B3.19B3.28B3.20B
Growth (%)-+53.12%+12.49%+4.45%+3.05%+36.85%+26.06%+34.97%+17.89%+23.36%+11.32%+12.59%+15.49%+9.94%+9.89%+4.44%+2.12%+13.05%+6.38%+16.21%+11.09%-10.81%-9.17%-12.56%-1.23%+12.18%-4.91%+19.58%+2.74%-2.56%
Cost of Revenue120.05M166.14M182.50M176.93M180.99M279.44M315.74M478.63M578.05M793.37M920.22M1.10B1.27B1.40B1.59B1.69B1.75B1.99B2.10B2.51B2.85B2.48B2.21B1.94B1.94B2.18B2.14B2.56B2.68B2.53B
Gross Profit76.78M135.26M156.55M177.21M183.96M219.98M313.82M371.09M423.70M442.43M455.51M453.54M518.66M562.77M571.28M565.10M552.55M614.44M670.48M706.86M732.56M706.84M692.17M597.55M561.29M628.17M528.55M637.06M605.17M666.98M
Gross Margin39.01%44.88%46.17%50.04%50.41%44.05%49.85%43.67%42.30%35.80%33.11%29.28%28.99%28.61%26.43%25.04%23.97%23.58%24.19%21.94%20.47%22.15%23.88%23.57%22.42%22.36%19.79%19.95%18.44%20.86%
Operating Expense42.01M33.12M36.18M44.64M37.46M64.74M135.97M189.86M271.25M229.31M175.75M28.04M410.45M261.78M296.85M303.13M359.08M368.62M365.31M384.85M449.32M484.03M328.34M349.07M436.01M431.00M398.54M489.49M562.21M630.75M
Operating Income34.78M102.14M120.37M132.57M146.51M155.23M177.85M181.23M152.45M213.11M279.77M425.50M108.20M300.99M274.43M261.97M193.46M245.83M305.16M322.01M283.24M222.81M363.83M248.48M125.28M197.17M130.01M147.56M42.96M36.23M
Operating Margin17.67%33.89%35.50%37.43%40.14%31.08%28.25%21.33%15.22%17.25%20.34%27.47%6.05%15.30%12.70%11.61%8.39%9.43%11.01%10.00%7.91%6.98%12.55%9.80%5.00%7.02%4.87%4.62%1.31%1.13%
EBITDA37.07M100.20M114.95M137.96M121.82M169.64M203.35M221.20M202.22M272.03M342.86M483.21M170.12M363.91M328.24M323.20M299.68M332.01M397.43M436.10M396.38M343.82M487.48M370.28M245.39M317.01M250.56M298.70M187.06M231.63M
EBITDA Margin18.84%33.25%33.91%38.96%33.38%33.97%32.30%26.03%20.19%22.01%24.92%31.20%9.51%18.50%15.19%14.32%13.00%12.74%14.34%13.54%11.08%10.77%16.81%14.61%9.80%11.29%9.38%9.35%5.70%7.24%
Net Income31.38M92.49M98.19M112.65M118.85M108.69M128.68M132.04M112.35M157.85M201.83M307.47M82.60M220.96M192.73M165.20M143.56M155.89M197.18M208.11M180.15M137.13M241.79M145.32M65.14M120.63M105.28M106.19M40.41M53.91M
Net Income Margin15.94%30.69%28.96%31.81%32.57%21.76%20.44%15.54%11.22%12.77%14.67%19.85%4.62%11.23%8.92%7.32%6.23%5.98%7.11%6.46%5.03%4.30%8.34%5.73%2.60%4.29%3.94%3.32%1.23%1.69%
R&D----------------33.85M36.41M40.14M41.04M35.98M39.39M34.12M43.92M43.71M57.01M74.17M79.14M110.69M110.14M
R&D as % of Total Revenue----------------1.47%1.40%1.45%1.27%1.01%1.23%1.18%1.73%1.75%2.03%2.78%2.48%3.37%3.44%
Interest Expense4.30M2.20M--01.10M2.44M1.88M3.15M4.04M5.71M2.39M541.06K748.87K3.87M6.20M9.51M10.30M9.75M7.66M8.18M11.33M3.52M1.05M983.74K952.97K906.68K1.37M3.07M5.22M
Interest Expense % of Total Revenue2.18%0.73%--0.00%0.22%0.39%0.22%0.31%0.33%0.41%0.15%0.03%0.04%0.18%0.27%0.41%0.40%0.35%0.24%0.23%0.36%0.12%0.04%0.04%0.03%0.03%0.04%0.09%0.16%

Balance Sheet

Currency: CNY1996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets247.41M306.16M432.49M1.17B1.22B1.42B1.54B1.64B1.79B1.84B2.03B2.37B2.20B2.46B2.74B2.96B3.20B3.30B3.62B3.85B3.86B3.86B3.88B4.16B4.28B4.45B4.54B4.55B6.09B6.01B
Total Liabilities77.25M80.23M119.63M153.24M161.37M306.54M296.79M256.06M322.83M280.42M330.39M416.86M324.25M400.59M544.47M633.01M733.12M729.94M871.24M925.73M804.90M803.11M638.90M733.62M850.43M913.10M916.30M865.58M1.24B1.18B
Total Equity170.16M223.80M310.37M1.02B1.06B1.07B1.14B1.27B1.35B1.43B1.55B1.76B1.70B1.85B1.97B2.05B2.12B2.20B2.32B2.44B2.54B2.59B2.74B2.88B2.86B2.93B2.99B3.04B3.79B3.78B
Cash40.62M73.69M88.15M466.13M418.51M443.75M506.45M542.65M503.20M503.80M510.42M673.65M783.42M751.31M868.06M933.83M975.92M944.83M726.99M698.18M756.13M907.54M965.54M1.47B1.32B1.50B1.50B1.43B1.77B1.52B
Total Debt21.00M25.80M50.90M16.00M-12.00M4.90M1.94M20.00M92.21M63.22M41.75M42.31M17.46M37.12M86.52M115.72M117.68M161.76M142.35M95.57M114.71M138.54M29.92M31.93M39.86M16.66M5.30M2.55M184.97M-
Net Debt-19.62M-47.89M-37.25M-450.13M-430.52M-438.85M-504.51M-522.65M-410.99M-440.58M-468.67M-631.35M-765.97M-714.19M-781.54M-818.12M-858.25M-783.07M-584.64M-602.61M-641.42M-769.01M-935.63M-1.43B-1.28B-1.49B-1.49B-1.42B-1.59B-

Cash Flow

Currency: CNY1999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow39.77M231.31M92.49M130.36M161.86M159.81M109.29M138.50M118.06M305.26M188.41M177.81M172.82M232.12M271.21M299.89M212.45M96.15M443.11M433.83M465.85M311.46M292.03M260.59M158.92M154.19M174.21M
Investing Cash Flow-266.69M-245.90M59.66M-55.85M-43.42M-151.94M-3.28M-10.51M165.60M-14.31M-134.93M-25.14M-46.48M-99.24M-177.30M-412.39M-107.67M21.12M-133.48M-95.31M123.55M-377.51M-69.12M-221.11M-370.16M-717.70M-
Financing Cash Flow604.89M-33.03M-126.48M-11.32M-82.23M-47.32M-105.42M-121.78M-120.38M-181.18M-87.60M-36.75M-57.72M-96.79M-119.00M-120.68M-143.53M-81.41M-122.24M-280.44M-89.59M-89.83M-39.65M-46.26M-43.27M806.42M-
Capital Expenditure71.57M134.49M160.27M102.63M56.73M72.47M36.61M23.09M20.97M22.11M96.60M95.48M82.20M188.76M144.05M91.14M104.31M107.45M66.80M136.42M125.71M291.41M162.76M309.64M186.25M201.63M157.87M
Free Cash Flow-31.80M96.81M-67.78M27.73M105.13M87.34M72.69M115.41M97.09M283.15M91.81M82.33M90.62M43.36M127.16M208.75M108.14M-11.30M376.31M297.41M340.13M20.06M129.26M-49.05M-25.85M-47.44M16.34M
Dividends Paid19.47M17.03M76.48M57.97M73.13M48.66M62.37M99.15M122.52M136.29M94.80M75.47M78.94M92.17M96.80M89.22M92.15M90.98M89.50M128.39M85.68M85.68M50.40M50.40M51.16M63.24M67.51M
FCF to OCF-79.97%41.86%-73.28%21.27%64.95%54.65%66.51%83.33%82.24%92.76%48.73%46.30%52.43%18.68%46.89%69.61%50.90%-11.76%84.93%68.55%73.01%6.44%44.26%-18.82%-16.27%-30.77%9.38%
Dividend Paid to FCF-61.23%17.59%-112.83%209.07%69.56%55.72%85.81%85.91%126.19%48.13%103.25%91.66%87.12%212.59%76.12%42.74%85.21%-804.91%23.78%43.17%25.19%427.18%38.99%-102.75%-197.89%-133.31%413.13%

Earnings

Report DateSep 30, 2007Mar 22, 2010Mar 31, 2010Jun 30, 2010Sep 30, 2010Dec 31, 2010Jun 1, 2011Aug 31, 2011Oct 24, 2011Feb 29, 2012Apr 23, 2012Aug 20, 2012Oct 22, 2012Feb 27, 2013Apr 24, 2013Aug 28, 2013Oct 28, 2013Mar 24, 2014May 28, 2014Aug 25, 2014Oct 27, 2014Mar 30, 2015Apr 29, 2015Aug 24, 2015Oct 26, 2015Mar 28, 2016Apr 25, 2016Aug 22, 2016Oct 28, 2016Mar 27, 2017Apr 28, 2017Aug 28, 2017Oct 30, 2017Mar 26, 2018Apr 26, 2018Aug 27, 2018Oct 29, 2018Mar 25, 2019Apr 30, 2019Aug 27, 2019Oct 29, 2019Mar 31, 2020Apr 28, 2020Aug 25, 2020Oct 30, 2020Mar 30, 2021Apr 27, 2021Aug 24, 2021Oct 27, 2021Mar 29, 2022Apr 28, 2022Aug 23, 2022Oct 28, 2022Mar 28, 2023Apr 29, 2023Aug 19, 2023Oct 31, 2023May 21, 2024Aug 27, 2024Oct 29, 2024May 21, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate-0.13------0.12-0.110.120.11-0.05-0.140.14-0.090.080.100.120.110.100.100.110.150.160.240.130.150.170.050.080.110.08-----------------------------
EPS Actual0.160.130.050.100.090.140.050.150.050.080.060.100.040.080.060.100.080.040.080.140.100.050.110.120.090.090.100.110.090.060.090.110.08-0.010.090.090.060.240.420.030.02-0.18-0.050.100.11-0.020.070.080.040.050.080.040.070.020.090.070.040.080.010.03-0.050.040.03-0.020.040.04
Surprise-0.00%-------58.33%--45.45%-16.67%-63.64%-20.00%--42.86%-71.43%-55.56%25.00%-50.00%-8.33%9.09%-10.00%-10.00%-9.09%-26.67%-43.75%-75.00%-30.77%-26.67%-52.94%-120.00%12.50%-18.18%-25.00%-----------------------------
Timing-Pre-market------After-hours-After-hoursAfter-hoursAfter-hours-After-hours-After-hoursAfter-hours-After-hoursPre-marketPre-marketAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-market-------------------After-hours--After-hours-----

Key Statistics & Ratios

Market Cap4.04B
Enterprise Value1.59B
Trailing P/E72.22
Forward P/E32.26
PEG Ratio1.15
Price / Sales1.27
Price / Book1.07
EPS0.09
Book Value6.06
Revenue (TTM)3.18B
Gross Profit (TTM)709.33M
EBITDA172.81M
Profit Margin1.76%
Operating Margin4.68%
Return on Equity1.18%
Return on Assets0.53%
Shares Outstanding621.92M
Shares Float333.73M
Beta0.22
Dividend Yield1.56%
Dividend Rate0.10
Payout Ratio111.11%

Dividends

20261×
0.10Jun 17, 2026
20251×
0.10Jul 8, 2025
20241×
0.10May 31, 2024
20231×
0.10Jul 14, 2023
20221×
0.10Aug 11, 2022
20211×
0.10Aug 12, 2021
20201×
0.17Aug 13, 2020
20191×
0.17Aug 15, 2019
20181×
0.17Jul 12, 2018
20171×
0.17Jul 27, 2017
20161×
0.17Jul 15, 2016
20151×
0.17Jun 26, 2015
20141×
0.16Jun 24, 2014
20131×
0.15Jul 5, 2013
20121×
0.15Jul 12, 2012
20111×
0.15Jul 20, 2011
20101×
0.15Jul 16, 2010
20091×
0.15Jul 17, 2009
20081×
0.28Jul 4, 2008
20071×
0.22Jul 13, 2007
20061×
0.17Jul 10, 2006
20051×
0.10Jul 13, 2005
20041×
0.06Aug 17, 2004
20031×
0.09Aug 15, 2003

Stock Splits

  • Jul 10, 20061.5:1
  • Feb 7, 200613.5:10
  • Aug 17, 200412:10